Search by Drug Name or NDC
NDC 49702-0223-18 SELZENTRY 150 mg/1 Details
SELZENTRY 150 mg/1
SELZENTRY is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is MARAVIROC.
MedlinePlus Drug Summary
Maraviroc is used along with other medications to treat a certain type of human immunodeficiency virus (HIV) infection in adults and children who weigh at least 4.4 lb (2 kg). Maraviroc is in a class of medications called HIV entry and fusion inhibitors. It works by decreasing the amount of HIV in the blood. Although maraviroc does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other lifestyle changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Related Packages: 49702-0223-18Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Maraviroc
Product Information
| NDC | 49702-0223 |
|---|---|
| Product ID | 49702-223_9165dbbc-c0cb-40b2-b7b6-5bfa02bb7979 |
| Associated GPIs | 12102060000320 |
| GCN Sequence Number | 062974 |
| GCN Sequence Number Description | maraviroc TABLET 150 MG ORAL |
| HIC3 | W5T |
| HIC3 Description | ANTIVIRALS, HIV-SPECIFIC, CCR5 CO-RECEPTOR ANTAG. |
| GCN | 98734 |
| HICL Sequence Number | 034927 |
| HICL Sequence Number Description | MARAVIROC |
| Brand/Generic | Brand |
| Proprietary Name | SELZENTRY |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | maraviroc |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | MARAVIROC |
| Labeler Name | ViiV Healthcare Company |
| Pharmaceutical Class | CCR5 Co-receptor Antagonist [EPC], Chemokine Co-receptor 5 Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022128 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49702-0223-18 (49702022318)
| NDC Package Code | 49702-223-18 |
|---|---|
| Billing NDC | 49702022318 |
| Package | 60 TABLET, FILM COATED in 1 BOTTLE (49702-223-18) |
| Marketing Start Date | 2011-05-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 27.9529 |
| Pricing Unit | EA |
| Effective Date | 2023-01-01 |
| NDC Description | SELZENTRY 150 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |